نتایج جستجو برای: soluble fas ligand

تعداد نتایج: 201321  

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2000
M Sata T Suhara K Walsh

Fas ligand (FasL) is a death factor that induces apoptosis in cells bearing its receptor, Fas. Fas and FasL have been detected in the vessel wall, and it has been proposed that Fas-mediated apoptosis has a role in physiological and pathological cell turnover in the vasculature. Here, we evaluated the expression of Fas in the presence and absence of cytokines on both endothelial cells (ECs) and ...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1999
D C Huang M Hahne M Schroeter K Frei A Fontana A Villunger K Newton J Tschopp A Strasser

Fas activation triggers apoptosis in many cell types. Studies with anti-Fas antibodies have produced conflicting results on Fas signaling, particularly the role of the Bcl-2 family in this process. Comparison between physiological ligand and anti-Fas antibodies revealed that only extensive Fas aggregation, by membrane bound FasL or aggregated soluble FasL consistently triggered apoptosis, where...

Journal: :Journal of immunology 1999
S B Brown J Savill

Human monocyte/macrophages (Mphi) exposed to nonparticulate stimuli can express cell surface Fas ligand (FasL) and release active soluble FasL (sFasL). We now report that monocyte/Mphi-ingesting opsonized zymosan released sFasL and conditioned supernatants so that these triggered Fas-mediated apoptosis of "bystander" monocytes and FasL-negative neutrophils. Furthermore, identical results were s...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2007
Luis M Blanco-Colio Jose L Martín-Ventura Eduardo de Teresa Csaba Farsang Allan Gaw GianFranco Gensini Lawrence A Leiter Anatoly Langer Pierre Martineau Gonzalo Hérnandez Jesús Egido

OBJECTIVE Increasing evidence indicates that the Fas/Fas ligand interaction is involved in atherogenesis. We sought to analyze soluble Fas (sFas) and soluble Fas ligand (sFasL) concentrations in subjects at high cardiovascular risk and their modulation by atorvastatin treatment. METHODS AND RESULTS ACTFAST was a 12-week, prospective, multicenter, open-label trial which enrolled subjects (stat...

Journal: :Journal of immunology 2005
Claudia Monari Eva Pericolini Giovanni Bistoni Arturo Casadevall Thomas R Kozel Anna Vecchiarelli

The major component of capsular material of Cryptococcus neoformans is glucuronoxylomannnan (GXM), a polysaccharide that exhibits potent immunosuppressive properties in vitro and in vivo. The results reported here show that 1) soluble purified GXM induces a prompt, long-lasting, and potent up-regulation of Fas ligand (FasL) on macrophages, 2) the up-regulation of FasL is related to induced synt...

Journal: :International heart journal 2012
Toru Kinugawa Masahiko Kato Kazuhiro Yamamoto Ichiro Hisatome Ryuji Nohara

The Fas/Fas Ligand system is a major apoptosis signaling pathway that is up-regulated in patients with chronic heart failure (CHF). Serum soluble Fas (sFas) levels increase in proportion to the CHF severity and may have prognostic value, therefore, sFas is a promising biomarker of heart failure. In this study, we attempted to identify the determinants of sFas levels in patients with CHF. Serum ...

Journal: :The Journal of Experimental Medicine 1996
H U Simon S Yousefi C C Dommann-Scherrer D R Zimmermann S Bauer J Barandun K Blaser

The mechanisms of sustained overproduction of eosinophils in the idiopathic hypereosinophilic syndrome and in some human immunodeficiency virus (HIV)-1-infected individuals are largely unknown. We hypothesized that T cells may release soluble products that regulate eosinophilia in these patients, as has been previously shown in bronchial asthma. We identified one patient with idiopathic hypereo...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید